Raman Spectroscopy Combined with Malaria Protein for Early Capture and Recognition of Broad-Spectrum Circulating Tumor Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Aug 12

PMID 37569448

Authors

Xinning Liu

Yidan Zhang

Xunrong Li

Jian Xu

Chenyang Zhao

Jinbo Yang

Affiliations

Soon will be listed here.

Abstract

Early identification of tumors can significantly reduce the mortality rate. Circulating tumor cells (CTCs) are a type of tumor cell that detaches from the primary tumor and circulates through the bloodstream. Monitoring CTCs may allow the early identification of tumor progression. However, due to their rarity and heterogeneity, the enrichment and identification of CTCs is still challenging. Studies have shown that Raman spectroscopy could distinguish CTCs from metastatic cancer patients. VAR2CSA, a class of malaria proteins, has a strong broad-spectrum binding effect on various tumor cells and is a promising candidate biomarker for cancer detection. Here, recombinant malaria VAR2CSA proteins were synthesized, expressed, and purified. After confirming that various types of tumor cells can be isolated from blood by recombinant malaria VAR2CSA proteins, we further proved that the VAR2CSA combined with Raman spectroscopy could be used efficiently for tumor capture and type recognition using A549 cell lines spiked into the blood. This would allow the early screening and detection of a broad spectrum of CTCs. Finally, we synthesized and purified the malaria protein fusion antibody and confirmed its in vitro tumor-killing activity. Herein, this paper exploits the theoretical basis of a novel strategy to capture, recognize, and kill broad-spectrum types of CTCs from the peripheral blood.

References

Paterlini-Brechot P . Circulating Tumor Cells: Who is the Killer?. Cancer Microenviron. 2014; 7(3):161-76. PMC: 4275541. DOI: 10.1007/s12307-014-0164-4. View

Reza K, Dey S, Wuethrich A, Wang J, Behren A, Antaw F . Single Cell Proteomics Reveals Circulating Tumor Cell Heterogeneity during Treatment. ACS Nano. 2021; 15(7):11231-11243. DOI: 10.1021/acsnano.0c10008. View

Rossi E, Fabbri F . CTCs 2020: Great Expectations or Unreasonable Dreams. Cells. 2019; 8(9). PMC: 6769853. DOI: 10.3390/cells8090989. View

Dodo K, Fujita K, Sodeoka M . Raman Spectroscopy for Chemical Biology Research. J Am Chem Soc. 2022; 144(43):19651-19667. PMC: 9635364. DOI: 10.1021/jacs.2c05359. View

Hardingham J, Grover P, Winter M, Hewett P, Price T, Thierry B . Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. Mol Med. 2015; 21 Suppl 1:S25-31. PMC: 4661051. DOI: 10.2119/molmed.2015.00149. View

Pantel K, Brakenhoff R, Brandt B . Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008; 8(5):329-40. DOI: 10.1038/nrc2375. View

Elumalai S, Manago S, De Luca A . Raman Microscopy: Progress in Research on Cancer Cell Sensing. Sensors (Basel). 2020; 20(19). PMC: 7582629. DOI: 10.3390/s20195525. View

Seiler R, Oo H, Tortora D, Clausen T, Wang C, Kumar G . An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. Eur Urol. 2017; 72(1):142-150. DOI: 10.1016/j.eururo.2017.03.021. View

Chau C, Steeg P, Figg W . Antibody-drug conjugates for cancer. Lancet. 2019; 394(10200):793-804. DOI: 10.1016/S0140-6736(19)31774-X. View

10.

Ahmadal-Agroudi M, El-Mawla Megahed L, Abdallah E, Morsy T . A MINI OVERVIEW OF MALARIA IN PREGNANCY. J Egypt Soc Parasitol. 2018; 47(1):177-196. View

11.

Tayoun T, Faugeroux V, Oulhen M, Aberlenc A, Pawlikowska P, Farace F . CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). Cells. 2019; 8(10). PMC: 6829286. DOI: 10.3390/cells8101145. View

12.

Haryanto A, Lee C . Shell isolated nanoparticle enhanced Raman spectroscopy for mechanistic investigation of electrochemical reactions. Nano Converg. 2022; 9(1):9. PMC: 8844332. DOI: 10.1186/s40580-022-00301-1. View

13.

Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pelle E . Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol. 2018; 10:1758835918794630. PMC: 6116068. DOI: 10.1177/1758835918794630. View

14.

Li H, Zhang P, Luo J, Hu D, Huang Y, Zhang Z . Chondroitin Sulfate-Linked Prodrug Nanoparticles Target the Golgi Apparatus for Cancer Metastasis Treatment. ACS Nano. 2019; 13(8):9386-9396. DOI: 10.1021/acsnano.9b04166. View

15.

Mehlen P, Puisieux A . Metastasis: a question of life or death. Nat Rev Cancer. 2006; 6(6):449-58. DOI: 10.1038/nrc1886. View

16.

Desai M, Kuile F, Nosten F, McGready R, Asamoa K, Brabin B . Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007; 7(2):93-104. DOI: 10.1016/S1473-3099(07)70021-X. View

17.

Nanduri L, Hissa B, Weitz J, Scholch S, Bork U . The prognostic role of circulating tumor cells in colorectal cancer. Expert Rev Anticancer Ther. 2019; 19(12):1077-1088. DOI: 10.1080/14737140.2019.1699065. View

18.

Layoun A, Samba M, Santos M . Isolation of murine peritoneal macrophages to carry out gene expression analysis upon Toll-like receptors stimulation. J Vis Exp. 2015; (98):e52749. PMC: 4541597. DOI: 10.3791/52749. View

19.

Lepone L, Donahue R, Grenga I, Metenou S, Richards J, Heery C . Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types. J Circ Biomark. 2017; 5:5. PMC: 5548330. DOI: 10.5772/62322. View

20.

Neng J, Zhang Q, Sun P . Application of surface-enhanced Raman spectroscopy in fast detection of toxic and harmful substances in food. Biosens Bioelectron. 2020; 167:112480. DOI: 10.1016/j.bios.2020.112480. View